TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.

Melissa A Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.